Alison W. Ashbrook

4.3k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Alison W. Ashbrook is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Alison W. Ashbrook has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Molecular Biology. Recurrent topics in Alison W. Ashbrook's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (8 papers) and Viral gastroenteritis research and epidemiology (4 papers). Alison W. Ashbrook is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (8 papers) and Viral gastroenteritis research and epidemiology (4 papers). Alison W. Ashbrook collaborates with scholars based in United States, Germany and Sweden. Alison W. Ashbrook's co-authors include Terence S. Dermody, Thomas E. Morrison, Laurie A. Silva, Charles M. Rice, Hans-Heinrich Hoffmann, Mark T. Heise, Margaret R. MacDonald, Scott W. Lowe, William M. Schneider and Joseph M. Luna and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Immunity.

In The Last Decade

Alison W. Ashbrook

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks

2020 243 citations William M. Schneider, Joseph M. Luna et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison W. Ashbrook United States	16	696	406	321	218	202	19	1.1k
Florian Douam United States	21	568 0.8×	288 0.7×	309 1.0×	317 1.5×	274 1.4×	37	1.2k
Mohamed Lamine Hafirassou France	10	424 0.6×	486 1.2×	244 0.8×	293 1.3×	180 0.9×	11	1.0k
Chia-Yi Yu Taiwan	19	651 0.9×	673 1.7×	444 1.4×	279 1.3×	422 2.1×	37	1.5k
Zhongyu Liu China	23	449 0.6×	576 1.4×	573 1.8×	164 0.8×	229 1.1×	64	1.5k
Nicholas S. Eyre Australia	18	319 0.5×	304 0.7×	323 1.0×	342 1.6×	349 1.7×	33	1.1k
Pietro Scaturro Germany	16	561 0.8×	766 1.9×	368 1.1×	235 1.1×	238 1.2×	26	1.3k
Blandine Monel France	12	603 0.9×	171 0.4×	408 1.3×	137 0.6×	254 1.3×	14	1.1k
Jillian M. Carr Australia	23	731 1.1×	729 1.8×	442 1.4×	262 1.2×	413 2.0×	72	1.7k
James T. Earnest United States	12	897 1.3×	264 0.7×	227 0.7×	207 0.9×	210 1.0×	14	1.2k
Zhigang Yi China	17	293 0.4×	127 0.3×	312 1.0×	211 1.0×	145 0.7×	52	838

Countries citing papers authored by Alison W. Ashbrook

Since Specialization

Citations

This map shows the geographic impact of Alison W. Ashbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison W. Ashbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison W. Ashbrook more than expected).

Fields of papers citing papers by Alison W. Ashbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison W. Ashbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison W. Ashbrook. The network helps show where Alison W. Ashbrook may publish in the future.

Co-authorship network of co-authors of Alison W. Ashbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Alison W. Ashbrook. A scholar is included among the top collaborators of Alison W. Ashbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison W. Ashbrook. Alison W. Ashbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lercher, Alexander, Jin‐Gyu Cheong, Michael J. Bale, et al.. (2024). Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease. Immunity. 57(11). 2530–2546.e13. 17 indexed citations

Ashbrook, Alison W., Niluka Goonawardane, Corrine Quirk, et al.. (2023). Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model. Vaccines. 11(3). 612–612. 10 indexed citations

Park, Jiwoon, Yuanyuan Zhao, Fan Zhang, et al.. (2022). IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease. Journal of Hepatology. 78(1). 45–56. 84 indexed citations

Adura, Carolina, Zakary S. Singer, Alison W. Ashbrook, et al.. (2022). Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis. Journal of Virology. 96(7). e0151621–e0151621. 5 indexed citations

Piscotta, Frank J., Hans-Heinrich Hoffmann, Young Joo Choi, et al.. (2021). Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals. mSphere. 6(6). e0071121–e0071121. 17 indexed citations

Saeed, Mohsan, Nicholas T. Hertz, Xianfang Wu, et al.. (2020). Defining the proteolytic landscape during enterovirus infection. PLoS Pathogens. 16(9). e1008927–e1008927. 36 indexed citations

Hoffmann, Hans-Heinrich, Francisco J. Sánchez‐Rivera, William M. Schneider, et al.. (2020). Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Cell Host & Microbe. 29(2). 267–280.e5. 108 indexed citations

Schneider, William M., Joseph M. Luna, Hans-Heinrich Hoffmann, et al.. (2020). Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell. 184(1). 120–132.e14. 243 indexed citations breakdown →

He, Xiao, Alison W. Ashbrook, Yang Du, et al.. (2020). RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology. Proceedings of the National Academy of Sciences. 117(32). 19465–19474. 41 indexed citations

10.

Knowlton, Jonathan J., Isabel Fernández de Castro, Alison W. Ashbrook, et al.. (2018). The TRiC chaperonin controls reovirus replication through outer-capsid folding. Nature Microbiology. 3(4). 481–493. 44 indexed citations

11.

Case, James Brett, Alison W. Ashbrook, Terence S. Dermody, & Mark R. Denison. (2016). Mutagenesis of S -Adenosyl- l -Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity. Journal of Virology. 90(16). 7248–7256. 52 indexed citations

12.

Ashbrook, Alison W., Paula F. Zamora, Laurie A. Silva, et al.. (2016). Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection. mBio. 7(3). 55 indexed citations

13.

Hawman, David W., Julie M. Fox, Alison W. Ashbrook, et al.. (2016). Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence. Cell Reports. 16(5). 1326–1338. 59 indexed citations

14.

Morrison, Thomas E., Julie M. Fox, Alison W. Ashbrook, et al.. (2016). Pathogenic chikungunya virus evades B cell responses to establish persistence. The Journal of Immunology. 196(1_Supplement). 147.12–147.12. 1 indexed citations

15.

Smith, Scott A., Laurie A. Silva, Julie M. Fox, et al.. (2015). Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host & Microbe. 18(1). 86–95. 106 indexed citations

16.

Mainou, Bernardo A., Alison W. Ashbrook, Everett Clinton Smith, et al.. (2015). Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry. Journal of Virology. 89(17). 8701–8712. 27 indexed citations

17.

Ashbrook, Alison W., Kristina S. Burrack, Laurie A. Silva, et al.. (2014). Residue 82 of the Chikungunya Virus E2 Attachment Protein Modulates Viral Dissemination and Arthritis in Mice. Journal of Virology. 88(21). 12180–12192. 83 indexed citations

18.

Silva, Laurie A., Solomiia Khomandiak, Alison W. Ashbrook, et al.. (2013). A Single-Amino-Acid Polymorphism in Chikungunya Virus E2 Glycoprotein Influences Glycosaminoglycan Utilization. Journal of Virology. 88(5). 2385–2397. 108 indexed citations

19.

Mainou, Bernardo A., Paula F. Zamora, Alison W. Ashbrook, et al.. (2013). Reovirus Cell Entry Requires Functional Microtubules. mBio. 4(4). 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact